DayTwo

DayTwo is a biotechnology company that develops a microbiome platform based on technologies such as artificial intelligence and provides consumers with nutritional supplements and health products. DayTwo focuses on personal health and is committed to offering personalized nutrition and health solutions to improve physical well-being. DayTwo offers a sustainable approach to alleviating metabolic diseases (diabetes, prediabetes, clinical obesity, non-alcoholic fatty liver disease) through gut microbiome sequencing, artificial intelligence, and virtual care. After ten years of scientific research and the development of AI-based algorithms, DayTwo’s virtual care solution reduces or eliminates medication by improving Time in Range and lowering glycated hemoglobin (A1C).